Illumina lowers Outlook due to China sales ban
The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the ...
At a launch event on Feb. 20, Roche detailed plans to enter Illumina's sequencing stronghold with a new platform. Roche's platform is in testing now and scheduled to launch commercially in 2026.
Next-generation sequencing (NGS) technology, which has been used at Illumina since 2007, builds upon earlier genome sequencing methods to greatly reduce the time taken to sequence DNA. When ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results